Theoretical studies on beta and delta isoform-specific binding mechanisms of phosphoinositide 3-kinase inhibitors
Jingyu Zhu1, Peichen Pan, Youyong Li
1Cyrus Tang Hematology Center, Soochow University, Suzhou, Jiangsu 215123, China. xinliangmao@suda.edu.cn.
Abstract:
Phosphoinositide 3-kinase (PI3K) is known to be closely related to tumorigenesis and cell proliferation, and controls a variety of cellular processes, including proliferation, growth, apoptosis, migration, metabolism, etc. The PI3K family comprises eight catalytic isoforms, which are subdivided into three classes. Recently, the discovery of inhibitors that block a single isoform of PI3K has continued to attract special attention because they may have higher selectivity for certain tumors and less toxicity for healthy cells. The PI3Kβ and PI3Kδ share fewer studies than α/γ, and therefore, in this work, the combination of molecular dynamics simulations and free energy calculations was employed to explore the binding of three isoform-specific PI3K inhibitors (COM8, IC87114, and GDC-0941) to PI3Kβ or PI3Kδ. The isoform specificities of the studied inhibitors derived from the predicted binding free energies are in good agreement with the experimental data. In addition, the key residues critical for PI3Kβ or PI3Kδ selectivity were highlighted by decomposing the binding free energies into the contributions from individual residues. It was observed that although PI3Kβ and PI3Kδ share the conserved ATP-binding pockets, individual residues do behave differently, particularly the residues critical for PI3Kβ or PI3Kδ selectivity. It can be concluded that the inhibitor specificity between PI3Kβ and PI3Kδ is determined by the additive contributions from multiple residues, not just a single one. This study provides valuable information for understanding the isoform-specific binding mechanisms of PI3K inhibitors, and should be useful for the rational design of novel and selective PI3K inhibitors.
Insights
Researchers explored how specific inhibitors bind to Phosphoinositide 3-kinase beta (PI3Kβ) and delta (PI3Kδ) isoforms. They found that multiple residues, not just one, determine inhibitor specificity for PI3Kβ or PI3Kδ.
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacology and Drug Discovery
Background:
- Phosphoinositide 3-kinase (PI3K) signaling is crucial for cell proliferation and tumorigenesis.
- Targeting specific PI3K isoforms offers potential for selective cancer therapies with reduced toxicity.
- PI3Kβ and PI3Kδ isoforms are less studied compared to others, highlighting a need for detailed investigation.
Purpose of the Study:
- To investigate the binding mechanisms of isoform-specific PI3K inhibitors to PI3Kβ and PI3Kδ.
- To identify key amino acid residues responsible for the selectivity of inhibitors towards PI3Kβ or PI3Kδ.
Main Methods:
- Employed molecular dynamics simulations to model inhibitor-protein interactions.
- Utilized free energy calculations to predict and quantify binding affinities.
- Decomposed binding free energies to pinpoint contributions from individual residues.
Main Results:
- Predicted isoform specificities of COM8, IC87114, and GDC-0941 aligned well with experimental data.
- Identified specific residues critical for distinguishing PI3Kβ and PI3Kδ binding.
- Confirmed that conserved ATP-binding pockets harbor distinct residues influencing selectivity.
Conclusions:
- Inhibitor specificity for PI3Kβ versus PI3Kδ is governed by the cumulative effects of multiple residues.
- This study provides insights into PI3K isoform-specific binding mechanisms.
- Findings support the rational design of novel, selective PI3K inhibitors for therapeutic applications.
More Related Videos
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
IP3/DAG Signaling Pathway
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway


